664 related articles for article (PubMed ID: 11126681)
21. Biphenotypic hybrid acute leukaemia detected by two colour flow cytometry.
Gudum HR; Chin YM; Menaka N; Jeyaranee S; Lin HP; Tay A
Malays J Pathol; 1992 Jun; 14(1):25-8. PubMed ID: 1469914
[TBL] [Abstract][Full Text] [Related]
22. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
Zelezníková T; Babusíková O
Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
[TBL] [Abstract][Full Text] [Related]
23. The presence of leukaemia-associated phenotypes is an independent predictor of induction failure in acute myeloid leukaemia.
Al-Mawali A; To LB; Gillis D; Hissaria P; Mundy J; Lewis I
Int J Lab Hematol; 2009 Feb; 31(1):61-8. PubMed ID: 19143870
[TBL] [Abstract][Full Text] [Related]
24. [Immunophenotyping of childhood leukemias--results of the first 100 bone marrow tests].
Klujber V; Koós R; Schuler D; Bocsi J
Orv Hetil; 1996 May; 137(21):1139-42. PubMed ID: 8757108
[TBL] [Abstract][Full Text] [Related]
25. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
26. [Monoclonal antibodies in diagnosis of acute leukemias].
Krawczyńska A; Robak T
Przegl Lek; 1996; 53(1):20-5. PubMed ID: 8711170
[TBL] [Abstract][Full Text] [Related]
27. [The diagnostic significance of blast immunophenotype assay in patients with acute leukemia].
Piatoska-Jakubas B; Pituch-Noworolska A; Skotnicki AB; Balana-Nowak A
Acta Haematol Pol; 1996; 27(1):33-41. PubMed ID: 8629441
[TBL] [Abstract][Full Text] [Related]
28. Shifts in expression of immunological cell markers in relapsed acute leukemia.
Tomová A; Babusíková O
Neoplasma; 2001; 48(3):164-8. PubMed ID: 11583283
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
Digiuseppe JA
Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
[TBL] [Abstract][Full Text] [Related]
30. Detection of minimal residual disease in acute leukemia.
van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
[TBL] [Abstract][Full Text] [Related]
31. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
Liu YR; Wang H; Chang Y; Cheng YF; Fu JY; Zhang LP; Liu GL; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical markers in acute leukaemias diagnosis.
Gluzman DF; Nadgornaya VA; Sklyarenko LM; Ivanovskaya TS; Poludnenko LY; Ukrainskaya NI
Exp Oncol; 2010 Sep; 32(3):195-9. PubMed ID: 21403617
[TBL] [Abstract][Full Text] [Related]
34. [Minimal residual disease detection in acute leukemia patients by flow cytometric assay of cross-lineage antigen expression].
Cho YU; Park CJ; Cha CH; Chi HS; Jang S; Kim MJ; Lee KH; Lee JH; Lee JH; Seo JJ; Im HJ
Korean J Lab Med; 2010 Dec; 30(6):533-9. PubMed ID: 21157135
[TBL] [Abstract][Full Text] [Related]
35. The significance of detecting WT1 expression in childhood acute leukemias.
Hu SY; Gu WY; Chen ZX; Wang XL; Cen JN; He HL; Chai YH; Chen CS
Pediatr Hematol Oncol; 2010 Nov; 27(8):581-91. PubMed ID: 20863155
[TBL] [Abstract][Full Text] [Related]
36. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T; Kern W
Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
[TBL] [Abstract][Full Text] [Related]
37. Minimal residual disease testing in acute leukemia by flow cytometry immunophenotyping: prognostic significance.
Ruiz-Argüelles GJ; Fernández-Lara D; Estrada-Gómez R; Manzano C; Ruiz-Delgado GJ; Pérez-Romano B; Ruiz-Argüelles A
Lab Hematol; 2007; 13(1):22-6. PubMed ID: 17353179
[TBL] [Abstract][Full Text] [Related]
38. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
39. Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis.
Hanson CA; Abaza M; Sheldon S; Ross CW; Schnitzer B; Stoolman LM
Br J Haematol; 1993 May; 84(1):49-60. PubMed ID: 7687860
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
